Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials.
Saved in:
| Title: | Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials. |
|---|---|
| Authors: | Ryvlin P; Department of Clinical Neurosciences, University Hospital of Lausanne and University of Lausanne, Lausanne, Switzerland., Dimova S; UCB Pharma, Brussels, Belgium., Elmoufti S; UCB Pharma, Morrisville, North Carolina, USA., Floricel F; UCB Pharma, Monheim am Rhein, Germany., Laloyaux C; UCB Pharma, Brussels, Belgium., Nondonfaz X; UCB Pharma, Braine-l'Alleud, Belgium., Biton V; Arkansas Epilepsy Program PA, Little Rock, Arkansas, USA. |
| Source: | Epilepsia [Epilepsia] 2022 Aug; Vol. 63 (8), pp. 2024-2036. Date of Electronic Publication: 2022 Jun 10. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1528-1167 |
|---|---|
| DOI: | 10.1111/epi.17304 |
